American Well Co. (NYSE:AMWL) Short Interest Up 7.9% in January

American Well Co. (NYSE:AMWL) saw a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 383,100 shares, a growth of 7.9% from the January 15th total of 355,000 shares. Approximately 3.3% of the shares of the company are sold short. Based on an average trading volume of 58,900 shares, the short-interest ratio is presently 6.5 days.

American Well Stock Performance

Shares of NYSE AMWL traded down $0.34 during midday trading on Tuesday, reaching $11.83. The stock had a trading volume of 178,430 shares, compared to its average volume of 72,795. The company has a market capitalization of $181.16 million, a price-to-earnings ratio of -0.81 and a beta of 1.18. American Well has a 12-month low of $5.00 and a 12-month high of $26.40. The stock has a 50-day moving average of $9.36 and a 200-day moving average of $9.19.

American Well (NYSE:AMWL) last issued its quarterly earnings results on Wednesday, February 12th. The company reported ($2.77) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($3.04) by $0.27. American Well had a negative return on equity of 52.49% and a negative net margin of 84.27%. As a group, analysts forecast that American Well will post -13.38 EPS for the current fiscal year.

Institutional Trading of American Well

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Senvest Management LLC boosted its stake in American Well by 3.9% in the 4th quarter. Senvest Management LLC now owns 1,300,611 shares of the company’s stock worth $9,429,000 after purchasing an additional 48,800 shares during the period. 4D Advisors LLC purchased a new position in shares of American Well in the fourth quarter worth $1,088,000. Geode Capital Management LLC boosted its position in shares of American Well by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 147,925 shares of the company’s stock worth $1,073,000 after acquiring an additional 922 shares during the last quarter. Bridgeway Capital Management LLC grew its stake in American Well by 39.4% during the fourth quarter. Bridgeway Capital Management LLC now owns 96,741 shares of the company’s stock valued at $701,000 after acquiring an additional 27,343 shares in the last quarter. Finally, Takeda Pharmaceutical Co. Ltd. purchased a new position in American Well during the fourth quarter valued at $564,000. Institutional investors own 56.05% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on AMWL shares. Needham & Company LLC restated a “hold” rating on shares of American Well in a research note on Thursday, February 13th. Wells Fargo & Company raised shares of American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 target price for the company in a report on Monday, January 13th. Morgan Stanley dropped their price target on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Truist Financial upped their price objective on American Well from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday. Finally, Stifel Nicolaus lifted their target price on American Well from $9.00 to $10.00 and gave the company a “hold” rating in a research report on Thursday, February 13th. Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to MarketBeat, American Well has an average rating of “Hold” and a consensus price target of $11.90.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.